Exemestane
Rank #484 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$14.5M
Total Cost
66,285
Total Claims
$14.5M
Total Cost
2,327
Prescribers
$218
Cost per Claim
10,089
Beneficiaries
133,809
30-Day Fills
$6,215
Avg Cost/Provider
28
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$14.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $14.5M total
Top Prescribers of Exemestane
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Monica Santiago Casiano | Hematology-Oncology | Yauco, Puerto Rico, PR | 57 | $67K |
| 2 | Katrina Simmons | Nurse Practitioner | Lowell, MA | 156 | $51K |
| 3 | Joseph Jones | Hematology-Oncology | Daphne, AL | 133 | $49K |
| 4 | Lindsey Prochaska | Hematology-Oncology | Wilmington, NC | 125 | $49K |
| 5 | Holly Cobb | Nurse Practitioner | Montgomery, AL | 130 | $48K |
| 6 | Heather Riggs Carter | Hematology-Oncology | Kettering, OH | 176 | $45K |
| 7 | Yadyra Rivera | Hematology-Oncology | Teaneck, NJ | 117 | $43K |
| 8 | Eugenio Galindo | Hematology-Oncology | Mcallen, TX | 240 | $43K |
| 9 | Amy Vander Woude | Hematology-Oncology | Grand Rapids, MI | 117 | $41K |
| 10 | Elaine Wade | Medical Oncology | Glenview, IL | 124 | $39K |
| 11 | Kathryn Edmiston | Hematology-Oncology | Worcester, MA | 133 | $39K |
| 12 | Maria Aloba | Hematology-Oncology | El Paso, TX | 233 | $38K |
| 13 | Juan Herrada | Hematology-Oncology | El Paso, TX | 190 | $36K |
| 14 | Carolyn Hendricks | Hematology-Oncology | Bethesda, MD | 92 | $35K |
| 15 | Stephanie Jeske | Hematology-Oncology | Santa Clara, CA | 109 | $34K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 481 | Lorlatinib (Lorbrena) | $14.7M | 720 |
| 482 | Rasagiline Mesylate (Rasagiline Mesylate) | $14.5M | 47,985 |
| 483 | Pazopanib Hcl (Votrient) | $14.5M | 1,156 |
| 484 | Exemestane (Exemestane) | $14.5M | 66,285 |
| 485 | Dihydroergotamine Mesylate (Dihydroergotamine Mesylate) | $14.4M | 6,855 |
| 486 | Clotrimazole/Betamethasone Dip (Clotrimazole-Betamethasone) | $14.4M | 503,015 |
| 487 | Verapamil Hcl (Verapamil Er) | $14.4M | 329,950 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology